Association of glucagon-like peptide-1 receptor agonists with risk of cancers-evidence from a drug target Mendelian randomization and clinical trials.
葡萄糖樣肽-1 受體激動劑與癌症風險的關聯性:來自藥物靶點 Mendelian 隨機化和臨床試驗的證據。
Int J Surg 2024-05-03
Glucagon-like-peptide 1 receptor agonism and attempted suicide: A Mendelian randomisation study to assess a potential causal association.
葡萄糖樣肽-1 受體激動劑與自殺企圖:一項孟德爾隨機化研究評估潛在的因果關係。
Clin Obes 2024-05-23
Glucagon-Like Peptide 1 Receptor Agonists Are Not Associated With an Increased Risk of Ileus or Intestinal Obstruction in Patients with Inflammatory Bowel Disease-A Danish Nationwide Cohort Study.
胰高血糖素樣肽-1 受體激動劑與炎症性腸病患者腸梗阻或腸道阻塞風險無關 - 一項丹麥全國性隊列研究。
Inflamm Bowel Dis 2024-11-27
Glucagon-like peptide-1 receptor agonists and the risk of erectile dysfunction: a drug target Mendelian randomization study.
胰高血糖素樣肽-1 受體激動劑與勃起功能障礙風險:一項藥物靶點的孟德爾隨機化研究。
Front Endocrinol (Lausanne) 2024-11-28
Exploring the Potential Effect of GLP1R Agonism on Common Ageing-Related Diseases via Glucose Reduction: A Mendelian Randomization Study.
探討 GLP1R 激動劑對常見老化相關疾病的潛在影響:透過降糖的孟德爾隨機化研究。
J Gerontol A Biol Sci Med Sci 2025-01-11
Association of glucagon-like peptide-1 receptor agonists with acute pancreatitis and biliary disease in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study.
糖尿病和肥胖患者中,胰高血糖素樣肽-1受體激動劑與急性胰腺炎和膽道疾病的關聯:一項傾向加權的基於人群的隊列研究。
Gac Sanit 2025-01-16
Exploring the causal relationship between GLP-1R agonists and diseases related to the thyroid and parathyroid: a mendelian randomization study.
探討 GLP-1R 激動劑與甲狀腺及副甲狀腺相關疾病之間的因果關係:一項孟德爾隨機化研究。
J Diabetes Metab Disord 2025-02-10
EVALUATING BOWEL OBSTRUCTION and ILEUS EVENTS in PATIENTS on GLP-1 RECEPTOR AGONISTS: A SYSTEMATIC REVIEW and META-ANALYSIS.
評估使用 GLP-1 受體激動劑患者的腸道阻塞和腸麻痺事件:系統性回顧與統合分析。
Expert Opin Drug Saf 2025-02-18
Impact of Glucagon-like Peptide-1 Receptor Agonists on Mental Illness: Evidence from a Mendelian Randomization Study.
Glucagon-like Peptide-1 受體激動劑對精神疾病的影響:來自孟德爾隨機化研究的證據。
Int J Mol Sci 2025-03-27